论著

多灶性与单灶性甲状腺乳头状癌的临床病理特征及超声表现的比较

展开
  • a.上海交通大学医学院附属瑞金医院 超声诊断科,上海 200025
    b.上海交通大学医学院附属瑞金医院 妇产科,上海 200025

收稿日期: 2020-08-10

  网络出版日期: 2022-06-28

基金资助

国家自然科学基金(82071923)

A comparison of clinicopathologic and ultrasonic features between unifocal and multifocal papillary thyroid carcinoma

Expand
  • a. Department of Ultrasound, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
    b. Department of Obstetrics and Gynecology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2020-08-10

  Online published: 2022-06-28

摘要

目的:探讨甲状腺乳头状癌(papillary thyroid carcinoma,PTC)中多灶癌与单灶癌的临床病理特征及超声表现的差异。方法:分析2007年1月至2019年1月于我院行超声检查并接受甲状腺全切手术的448例PTC患者,其中单灶癌患者155例(单灶组),多灶癌患者293例(多灶组),采用χ2检验及非参数检验比较单灶组与多灶组之间的临床病理特征及超声表现差异。结果:在临床病理特征方面,PTC多灶组中微小癌(72%比63%,P=0.049)、淋巴结转移(56%比41%,P=0.004)及包膜浸润(10%比3%,P=0.009)显著多于单灶组,而合并结节性甲状腺肿情况比单灶组少(42%比56%,P=0.003)。在超声表现方面,相较于单灶组,多灶组中癌结节更易出现在甲状腺中央背侧及中间外侧(P值分别为0.029、0.008,P值分别为0.002、0.011),3根径线(上下径、前后径、左右径)长度均显著小于单灶组(P值分别为0.004、0.001、0.023),而多灶组中边界模糊(67%比77%,P=0.013)、内部回声不均匀(79%比88%,P=0.009)、钙化(50%比63%,P=0.010)及后方回声改变(18%比28%,P=0.008)的结节少于单灶组。结论:多灶性PTC患者中发生淋巴结转移及包膜浸润者更多,可以进行相对更积极的治疗;超声表现比较分析显示,相对于单灶性PTC,多灶性PTC结节更易出现在甲状腺中央背侧及中间外侧,且癌灶体积较小,因此医师应对其更加重视,减少漏诊、误诊。

本文引用格式

杨一娴, 倪仲馨, 夏蜀珺, 周伟, 詹维伟 . 多灶性与单灶性甲状腺乳头状癌的临床病理特征及超声表现的比较[J]. 诊断学理论与实践, 2021 , 20(02) : 168 -172 . DOI: 10.16150/j.1671-2870.2021.02.009

Abstract

Objective: To investigate the difference in the clinicopathologic and ultrasonic features between unifocal and multifocal papillary thyroid carcinomas. Methods: A total of 448 cases with papillary thyroid carcinoma undergone total thyroidectomy were enrolled during Jan. 2007 to Jan. 2019. Patients were divided into two groups which were unifocal tumor group (155 cases) and multifocal tumor group (293 cases). The difference in clinicopathologic and ultrasonic features between two groups were compared using χ2 test and non-parametric tests. Results: The pathological examination revealed that the multifocal tumors presented more microcarcinoma (72% vs 63%, P=0.049), lymph node metastasis (LMN) (56% vs 41%, P=0.004), capsular invasion (10% vs 3%, P=0.009) and less nodular goiter (42% vs 56%, P=0.003) than those of unifocal tumors. Comparing to unifocal tumors, the multifocal tumors occurred more in the middle dorsal and medial lateral side of the thyroid (P=0.029, P=0.008; P=0.002, P=0.011), and their size measured with three diameters(vertical anteroposterior, left right diameters) was smaller (P=0.004, P=0.001, P=0.023) in ultrasonography. In addition, the multifocal group had less unclear boundary (67% vs 77%, P=0.013), heterogeneous internal echoes (79% vs 88%, P=0.009), calcification (50% vs 63%, P=0.010) and pos-terior echo change (18% vs 28%, P<0.008) than the unifocal group. Conclusions: The multifocal tumors have more LNM and capsular invasion, presenting more aggressive clinicopathological features, which means active management may be required. The ultrasonic imaging shows multifocal tumors tend to locate in the middle dorsal and medial lateral side of the thyroid and the size of them are smaller, which makes it easy to lead to the missed diagnosis or misdiagnosis. Therefore, more attention should be given to it in clinical practice.

参考文献

[1] Kitahara CM, Sosa JA. The changing incidence of thyroid cancer[J]. Nat Rev Endocrinol, 2016, 12(11):646-653.
[2] 冯红芳, 陈创, 孙圣荣, 等. 1585例甲状腺癌的临床病理特点及总结分析[J]. 中国肿瘤临床, 2015, 53(2):77-81.
[3] Harries V, Wang LY, McGill M, et al. Should multifoca-lity be an indication for completion thyroidectomy in pa-pillary thyroid carcinoma?[J]. Surgery, 2020, 167(1):10-17.
[4] Wang W, Su X, He K, et al. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: an updated study with more than 2000 consecutive patients[J]. Cancer, 2016, 122(2):198-206.
[5] Medas F, Tuveri M, Canu GL, et al. Complications after reoperative thyroid surgery: retrospective evaluation of 152 consecutive cases[J]. Updates Surg, 2019, 71(4):705-710.
[6] 逄仁柱, 孟宪瑛, 孙雪, 等. 多灶性甲状腺乳头状癌生物学特性的探讨[J]. 中华普通外科杂志, 2015, 30(2):161-162.
[7] Kaliszewski K, Zubkiewicz-Kucharska A, Wojtczak B, et al. Multi- and unifocal thyroid microcarcinoma: are there any differences?[J]. Adv Clin Exp Med, 2016, 25(3):485-492.
[8] 林益凯, 盛建明, 赵文和, 等. 多灶性甲状腺乳头状癌168 例临床研究[J]. 中华外科杂志, 2009, 47(6):450-453.
[9] Singhal S, Sippel RS, Chen H, et al. Distinguishing classical papillary thyroid microcancers from follicular-variant microcancers[J]. J Surg Res, 2014, 190(1):151-156.
[10] Joseph KR, Edirimanne S, Eslick GD. Multifocality as a prognostic factor in thyroid cancer: a meta-analysis[J]. Int J Surg, 2018, 50:121-125.
[11] Tam AA, Özdemir D, Çuhacı N, et al. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer[J]. Endocrine, 2016, 53(3):774-783.
[12] Al Afif A, Williams BA, Rigby MH, et al. Multifocal pa-pillary thyroid cancer increases the risk of central lymph node metastasis[J]. Thyroid, 2015, 25(9):1008-1012.
[13] Lee JH, Kim Y, Choi JW, et al. The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis[J]. Eur J Endocrinol, 2013, 168(3):343-349.
[14] Uhliarova B, Hajtman A. Hashimoto′s thyroiditis—an independent risk factor for papillary carcinoma[J]. Braz J Otorhinolaryngol, 2018, 84(6):729-735.
[15] Ma H, Li L, Li K, et al. Hashimoto's thyroiditis, nodular goiter or follicular adenoma combined with papillary thyroid carcinoma play protective role in patients[J]. Neoplasma, 2018, 65(3):436-440.
[16] Moon S, Chung HS, Yu JM, et al. Associations between Hashimoto thyroiditis and clinical outcomes of papillary thyroid cancer: a meta-analysis of observational studies[J]. Endocrinol Metab (Seoul), 2018, 33(4):473-484.
[17] 王刚平, 张红, 武杰, 等. 多灶性甲状腺乳头状癌生物学行为分析[J]. 山东医药, 2011, 51(29):72-73.
[18] Vasileiadis I, Karakostas E, Charitoudis G, et al. Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients[J]. Eur J Clin Invest, 2012, 42(6):657-664.
[19] 严丽, 李清怀, 冀宏, 等. 多灶甲状腺微小乳头状癌的临床特征分析[J]. 中国普通外科杂志, 2016, 025(011):1568-1572.
[20] Yan L, Blanco J, Reddy V, et al. Clinicopathological features of papillary thyroid microcarcinoma with a diameter less than or equal to 5 mm[J]. Am J Otolaryngol, 2019, 40(4):560-563.
[21] Kaliszewski K, Diakowska D, Wojtczak B, et al. The occurrence of and predictive factors for multifocality and bilaterality in patients with papillary thyroid microcarcinoma[J]. Medicine (Baltimore), 2019, 98(19):e15609.
文章导航

/